News
Stay Ahead with the Latest Industry Trends & Market Insights with Industry News 📰

North America Digital Pathology Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: November 2023 || SKU: HCIT7034
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
Get Free Sample

Get Expert Insights on North America Digital Pathology Market

Talk to analysts, not algor

North America Digital Pathology Market is Segmented By Product (Software, Scanners, Storage Systems, Communication Systems, Others), By Application (Drug Discovery, Teleconsultation, Diagnosis, Training & Education, Others), By Type (Human Pathology, Veterinary Pathology), By Technology (Whole Slide Imaging, Telepathology), By End-User (Hospital laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Research & Academic Institutes, Others), and By Country (U.S., Canada, Mexico) - Share, Size, Outlook, and Opportunity Analysis, 2023-2030 

 

North America Digital Pathology Market Overview

The North America digital pathology market is estimated to grow at a CAGR of 12.5% from 2023 to 2030. 

The North America Digital Pathology market refers to the procedure of turning glass slides into digital pictures utilizing modern scanning technologies. Using sophisticated software, these digital pictures may be saved, examined, and analyzed. This technology allows pathologists to remotely view and exchange pathology data, which improves teamwork and decision-making.

North America Digital Pathology Market Scope

Metrics

Details

CAGR

12.5%

Size Available for Years

2021-2030

Forecast Period

2023-2030

Data Availability

Value (US$)

Segments Covered

Type, Product, Technology, Application, and End-User

Countries Covered

U.S., Canada, Mexico

Largest Country

U.S.

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.

 

For more details on this report Request for Sample

 

North America Digital Pathology Market Dynamics

Numerous advantages come with digital pathology, such as enhanced diagnostic precision, quicker response times, remote access to pathology data, and more efficient professional communication. The use of cutting-edge diagnostic technologies, such as digital pathology, is now required for fast and accurate detection due to the rising incidence of cancer in North America. Constant progress in AI, machine learning algorithms, and digital imaging has extended the potential of digital pathology, allowed automated analysis and supported precision medicine.

North America Digital Pathology Market Opportunities

The increasing demand for remote healthcare services allows digital pathology providers to broaden their telepathology offerings, facilitating access to professional consultations regardless of geographic location. There are prospects for cooperation between pathology and AI technology businesses as a result of the integration of digital pathology with AI algorithms, which may improve treatment results, enable predictive analytics, and increase diagnostic accuracy.

With scalability, cost-effectiveness, and seamless data exchange provided by cloud-based digital pathology systems, healthcare organizations can use digital pathology without having to make large infrastructure expenditures.

North America Digital Pathology Market Segmentation Analysis

The North America Digital Pathology Market is segmented By Product into Software, Scanners, Storage Systems, and Communication Systems; By Application into Drug Discovery, Teleconsultation, Diagnosis, Training and education; By Type into Human Pathology and veterinary Pathology; By Technology into Whole Slide Imaging, Telepathology, Static Telepathology, Dynamic Telepathology; By End-User into Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Research & Academic Institutes, Hospital laboratories.

  • Based on Product Insights, the scanners segment plays a crucial role in digital pathology, capturing high-resolution glass slide images. The demand for advanced scanners with faster scanning capabilities, higher image quality, and automation features is increasing in the market.
  • The Communication Systems segment facilitates the exchange of digital pathology data between healthcare professionals, enabling telepathology services and remote consultations. The market is witnessing the integration of communication systems with electronic medical records and telehealth platforms.
  • Storage Systems Segment as the volume of digital pathology data increases, the demand for secure and scalable storage systems is growing. Cloud-based storage solutions are gaining popularity, offering flexibility, accessibility, and cost-effectiveness.

North America Digital Pathology Market Geographical Share

The North America Digital Pathology market can be segmented into the United States and Canada. 

The United States holds a significant market share, attributed to the presence of advanced healthcare infrastructure, increased adoption of digital pathology solutions, and a high burden of chronic diseases. The country has witnessed rapid technological advancements in the field, with key market players investing in research and development activities.

Canada is also experiencing growth in the digital pathology market, driven by government initiatives promoting healthcare digitization, increasing demand for efficient diagnostic tools, and collaborations between healthcare institutions and technology providers.

North America Digital Pathology Market Companies

key players are Philips Healthcare, Leica Biosystems, Roche Diagnostics, Hologic, Inc, Hamamatsu Photonics., PerkinElmer, 3DHISTECH, Proscia, OptraSCAN.

Why purchase North America Digital Pathology Market report?

Technological Innovations

Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.

Product Performance & Market Positioning

Analyzes product performance, market positioning, and growth potential to optimize strategies.

Real-World Evidence

Integrates patient feedback and data into product development for improved outcomes.

Physician Preferences & Health System Impact

Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.

Market Updates & Industry Changes

Covers recent regulatory changes, new policies, and emerging technologies.

Competitive Strategies

Analyzes competitor strategies, market share, and emerging players.

Pricing & Market Access

Reviews pricing models, reimbursement trends, and market access strategies.

Market Entry & Expansion

Identifies optimal strategies for entering new markets and partnerships.

Regional Growth & Investment

Highlights high-growth regions and investment opportunities.

Supply Chain Optimization

Assesses supply chain risks and distribution strategies for efficient product delivery.

Sustainability & Regulatory Impact

Focuses on eco-friendly practices and evolving regulations in healthcare.

Post-market Surveillance

Uses post-market data to enhance product safety and access.

Pharmacoeconomics & Value-Based Pricing

Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

Target Audience 2025

Manufacturers

Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.

Regulatory & Policy

Compliance Officers, Government, Health Economists, Market Access Specialists.

Application & Innovation

AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.

Investors

Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.

Consulting & Advisory

Healthcare Consultants, Industry Associations, Analysts.

Supply Chain

Distribution and Supply Chain Managers.

Consumers & Advocacy

Patients, Advocacy Groups, Insurance Companies.

Academic & Research

Academic Institutions.

Buy this report
Single User
$3750$3000
Multiple User
$4000$3200
Enterprise User
$7250$5800
Proceed to Buy
  Get Free Sample
  Customize Sample
  Demo Full Report
Chat on WhatsApp
FAQ’s

  • North America Digital Pathology Market is expected to grow at a high CAGR of 12.5% during the forecasting period (2023-2030).

  • key players are Philips Healthcare, Leica Biosystems, Roche Diagnostics, Hologic, Inc, Hamamatsu Photonics., PerkinElmer, 3DHISTECH, Proscia, OptraSCAN.

  • U.S. is the Largest Market Share in North America Digital Pathology Market.

  • The segments are By Type, By Product, By Technology, By Application, and By End-User.
Related Reports
healthcare-it iconhealthcare-it

Europe Digital Pathology Market Size, Share, Growth Insights and Forecast 2025-2033

Published: 2025 January 20

Starting from

$3750

healthcare-it iconhealthcare-it

Asia Pacific Digital Pathology Market Size, Share, Industry, Forecast and outlook (2018-2033)

Published: 2025 January 31

Starting from

$3750

healthcare-it iconhealthcare-it

Latin America Digital Pathology Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2023 December 21

Starting from

$3750

medical-devices iconmedical-devices

Vein Finders Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 September 03

Starting from

$4350

healthcare-it iconhealthcare-it

Digital Diabetes Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 September 03

Starting from

$4350

healthcare-it iconhealthcare-it

Mental Health Apps Market Size, Share Analysis, Growth Trends and Forecast 2025-2033

Published: 2025 May 19

Starting from

$4350

WhatsApp